Relapse/Refratory Peripheral T Cell Lymphoma
1 clinical trials · Condition
◉ Watch Relapse/Refratory Peripheral T Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Chidamide Combined With Cyclophosphamide, Prednisone, Thalidomide in Treatment of Fragile Patients With Relapse/Refratory Peripheral T Cell Lymphoma (NCT02879526) | The First Affiliated Hospital with Nanjing Medical University | 2016-08-01 |
Track Relapse/Refratory Peripheral T Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.